Non-Nucleoside Reverse Transcriptase Inhibitors
- Name
- Non-Nucleoside Reverse Transcriptase Inhibitors
- Accession Number
- DBCAT002245
- Description
Not Available
- ATC Classification
- Drugs
Drug Drug Description Delavirdine A non-nucleoside reverse transcriptase inhibitor used to treat HIV infection. Etravirine A non-nucleoside reverse transcriptase inhibitor (NNRTI) used in the treatment of HIV-1 infections in combination with other antiretroviral agents. Nevirapine A non-nucleoside reverse transcriptase inhibitor used as part of a management regimen for HIV-1 virus infection. Efavirenz A non-nucleoside reverse transcriptase inhibitor used to treat HIV infection or prevent the spread of HIV. Rilpivirine A non-nucleoside reverse transcriptase inhibitor (NNRTI) used in combination with other antiretrovirals to specifically treat human immunodeficiency virus type 1 (HIV-1). Doravirine A non-nucleoside reverse transcriptase inhibitor used in combination with other antiretrovirals to treat HIV-1 infections. Opaviraline Not Available Capravirine Investigated for use/treatment in acquired immune deficiency syndrome (AIDS) and aids-related infections and HIV infection. - Drugs & Drug Targets